Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Big Pharma
Biotech
Big pharma cuts and gene therapy woes: Inside Q3's layoffs
If the layoff rate remains constant, one could expect 252 workforce reductions by the end of the year—a 27 percentage point jump from 2024.
Gabrielle Masson
Oct 3, 2025 4:30pm
Expect further market correction in tariff-driven era: PitchBook
Apr 18, 2025 7:51am
German program matches lost NIH grants with pharma funders
Apr 7, 2025 10:50am
R&D cost per drug up year over year: Deloitte
Mar 25, 2025 12:01am
East Asians underrepresented in biopharma C-suites: report
Jan 27, 2025 3:00am
Big Pharma layoff rounds jump 281% in 2024
Jan 3, 2025 3:29pm
